000			01112 a2200313 4500
005			20250513132734.0
264		0	_c19971208
008			199712s 0 0 spa d
022			_a0034-0634
040			_aNLM _beng _cNLM
100	1		_aStadler, P
245	0	0	_a[Influence of biotechnology and genetic engineering in medical therapy]. _h[electronic resource]
260			_bAnales de la Real Academia Nacional de Medicina _c1997
300			_a405-17 p. _bdigital
500			_aPublication Type: Address
650	0	4	_aAcarbose
650	0	4	_aAcquired Immunodeficiency Syndrome _xdrug therapy
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aAprotinin _xtherapeutic use
650	0	4	_aBiotechnology
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aFactor VIII _xbiosynthesis
650	0	4	_aGenetic Engineering
650	0	4	_aGenetic Therapy
650	0	4	_aHemophilia A _xtherapy
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aTrisaccharides _xtherapeutic use
773	0		_tAnales de la Real Academia Nacional de Medicina _gvol. 114 _gno. 2 _gp. 405-17
999			_c9381831 _d9381831